Keywords: aeterna, zentaris, regains, rights, cetrorelix, solvay, canadian

AEterna Zentaris regains rights to cetrorelix from Solvay

Article | 14 May 2007

Canadian drugmaker AEterna Zentaris has regained full exclusive worldwide (ex-Japan) rights for its lead luteinizing hormone-releasing hormone (LHRH) antagonist, cetrorelix ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Solvay

Go to company listing

Related Drugs

Cetrorelix

Cetrotide

Go to drug listing